The impact of admission red cell distribution width on the development of poor myocardial perfusion after primary percutaneous intervention
| Autor: | Mustafa Kurt, Huseyin Uyarel, Turgay Isik, Erkan Ayhan, Ibrahim Halil Tanboga, Mehmet Ergelen |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Erythrocyte Indices
Male medicine.medical_specialty Percutaneous medicine.medical_treatment Myocardial Infarction Percutaneous Coronary Intervention Internal medicine medicine Humans cardiovascular diseases Myocardial infarction Aged biology business.industry C-reactive protein Percutaneous coronary intervention Red blood cell distribution width Tirofiban Middle Aged medicine.disease C-Reactive Protein Conventional PCI Cardiology biology.protein No-Reflow Phenomenon Female Cardiology and Cardiovascular Medicine business Perfusion medicine.drug |
| Zdroj: | Atherosclerosis. 224:143-149 |
| ISSN: | 0021-9150 |
| DOI: | 10.1016/j.atherosclerosis.2012.06.017 |
| Popis: | The purpose of this study was to evaluate the predictive value of red cell distribution width (RDW) on the electrocardiographic no-reflow phenomenon in patients undergoing primary percutaneous coronary intervention (PCI).One-hundred consecutive patients (mean age 61.3 ± 12.8 years and male 77%) with ST-elevation myocardial infarction, who were treated with primary PCI, were analyzed prospectively. RDW and high sensitive C reactive protein (hs-CRP) were measured. The sum of ST-segment elevation was obtained immediately before and 60 min after the restoration of coronary flow. The difference between two measurements was accepted as the amount of ST-segment resolution and was expressed as ∑STR. ∑STR50% was accepted as electrocardiographic sign of no-reflow phenomenon.There were 30 patients in the no-reflow group (Group 1) and 70 patients in the normal re-flow group (Group 2). RDW and hs-CRP levels on admission were higher in Group 1. An RDW level ≥14% measured on admission had 70% sensitivity and 64% specificity in predicting no-reflow on ROC curve analysis. Mid-term cardiovascular events were significantly higher in Group 1. In multivariate analyses, RDW (OR 2.93,95% CI 1.42-6.04; p = 0.004), and tirofiban (OR 0.16,95% CI 0.05-0.48; p = 0.001) were independent predictors of no-reflow, and RDW (OR 5.89,95% CI 1.63-21.24; p = 0.007), and creatine kinase-MB (CK-MB) on admission (OR 1.01,95% CI 1.00-1.02; p = 0.006) were independent predictors of mid-term mortality.A greater baseline RDW value was independently associated with the presence of electrocardiographic no-reflow. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect